1-14 of 14
Rong Liang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

Clinical Trials & Observations
Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Yanli Zhang, Na Xu, Robert Peter Gale, Weiming Li, Xiaoli Liu, Huanling Zhu, Ling Pan, Yunfan Yang, Hai Lin, Xin Du, Rong Liang, Chunyan Chen, Xiaodong Wang, Guohui Li, Zhuogang Liu, Yanqing Zhang, Zhenfang Liu, Jianda Hu, Chunshui Liu, Fei Li, Wei Yang, Li Meng, Yanqiu Han, Li’e Lin, Zhenyu Zhao, Chuanqing Tu, Caifeng Zheng, Yanliang Bai, Zeping Zhou, Suning Chen, Huiying Qiu, Lijie Yang, Xiuli Sun, Hui Sun, Li Zhou, Zelin Liu, Danyu Wang, Jianxin Guo, Liping Pang, Qingshu Zeng, Xiaohui Suo, Weihua Zhang, Yuanjun Zheng, Xiaojun Huang, Qian Jiang
Journal: Blood
Blood (2024) 144 (18): 1951–1961.
https://doi.org/10.1182/blood.2024024761
Published: 2024
Includes: Supplemental data
Journal Articles

Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide (CPCT) for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Multicenter Phase II Trial

Wei Xu, Jin-Hua Liang, Li Wang, Xiao-Dong Wang, Guohui Cui, Jianfeng Zhou, Jingyan Xu, Luqun Wang, Rong Liang, Bi-yun Chen, Jian Cheng, Jian-Yong Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 9484–9486.
https://doi.org/10.1182/blood-2022-157014
Published: 2022
Journal Articles

Subjects with Chronic Myeloid Leukemia Identified As Intermediate- or High-Risk Subjects Using the Imatinib Therapy Failure (IMTF) Model Benefit from Initial Therapy with a Second-Generation Tyrosine Kinase Inhibitor

Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Gongli Zhang, Xiaoli Liu, Na Xu, Weiming Li, Xin Du, Jianyu Weng, Hai Lin, Rong Liang, Chunyan Chen, Huanling Zhu, Ling Pan, Yun-fan Yang, Xiaodong WANG, Guohui Li, Zhuogang Liu, Zhenfang Liu, Jianda Hu, Chunshui Liu, Li Fei, Wei Yang, Li Meng, Robert Peter Gale, Xiao Jun Huang, Qian Jiang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3891–3894.
https://doi.org/10.1182/blood-2022-168812
Published: 2022
Journal Articles

Is the 2 nd Generation Tyrosine Kinase-Inhibitor a Better Initial Therapy Than Imatinib in Persons with Chronic Myeloid Leukemia Presenting in Accelerated Phase: A Multicenter Retrospective Study

Sen Yang, Xiaoshuai Zhang, Yanli Zhang, Xin Du, Jianyu Weng, Huanling Zhu, Ling Pan, Yun-fan Yang, Li Meng, Zhenfang Liu, Xiaoli Liu, Na Xu, Chunyan Chen, Xiaodong WANG, Rong Liang, Jian Huang, Guohui Li, Chunshui Liu, Hai Lin, Jianda Hu, Li Fei, Bingcheng Liu, Weiming Li, Zhuogang Liu, Wei Yang, Xiao Jun Huang, Qian Jiang
Journal: Blood
Blood (2022) 140 (Supplement 1): 815–817.
https://doi.org/10.1182/blood-2022-166855
Published: 2022
Journal Articles

Validation and Use of Predictive Scoring Systems for Molecular Responses in 5,203 Persons with Chronic Myeloid Leukemia

Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Gongli Zhang, Xiaoli Liu, Na Xu, Weiming Li, Xin Du, Jianyu Weng, Hai Lin, Rong Liang, Chunyan Chen, Huanling Zhu, Ling Pan, Yunfan Yang, Xiaodong WANG, Guohui Li, Zhuogang Liu, Zhenfang Liu, Jianda Hu, Chunshui Liu, Li Fei, Wei Yang, Li Meng, Robert Peter Gale, Xiao Jun Huang, Qian Jiang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9620–9623.
https://doi.org/10.1182/blood-2022-166431
Published: 2022
Journal Articles

A Predictive Scoring System for Therapy Failure in Persons with Chronic Myeloid Leukemia Receiving Initial a Second-Generation Tyrosine Kinase Inhibitor Therapy

Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Gongli Zhang, Xiaoli Liu, Na Xu, Weiming Li, Xin Du, Jianyu Weng, Hai Lin, Rong Liang, Chunyan Chen, Huanling Zhu, Ling Pan, Yun-fan Yang, Xiaodong WANG, Guohui Li, Zhuogang Liu, Zhenfang Liu, Jianda Hu, Chunshui Liu, Li Fei, Wei Yang, Li Meng, Robert Peter Gale, Xiao Jun Huang, Qian Jiang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9637–9639.
https://doi.org/10.1182/blood-2022-168703
Published: 2022
Journal Articles

Research of miR-30b in Cisplatin Resistance of Human NK/T Cell Lymphoma Lines SNK-6 and YTS Cells By Targeting CCL22

Rong Liang, MD PhD, Jian hong Wang, MD, Fang Liu, MD, Xiao hui Duan, MD, Xia Cai Hao, MD, Liang Zhang, MD PhD, Michael Wang, MD, Xiang -xiang Liu, MD, Yan Hua Guo, MD, Zhe Wang, PhD, Hailong Tang, PhD, Ljie Yang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5302.
https://doi.org/10.1182/blood-2018-99-114405
Published: 2018
Journal Articles

Primary Breast Diffuse Large B Cell Lymphoma in the Rituximab Era: Outcomes of a Multicenter Retrospective Study By the Lymphoma and Leukemia Committee of Chinese Geriatric Oncology Society(LLC-CGOS)

Shaoxuan Hu, MD, Yuqin Song, MD, Yufu Li, MD, Xiuhua Sun, MD, Liping Su, MD, Wei Zhang, MD, Jing Jia, MD, Ou Bai, MD, Rong Liang, MD, Xiaoling Li, MD, Huilai Zhang, MD, Yuhuan Gao, MD, Weijing Zhang, MD, Xiubin Xiao, MD, Huizheng Bao, MD, Ningju Wang, MD, Hanyun Ren, MD, Xinan Cen, MD, Shun'e Yang, MD, Yu Zhao, MD, Yinan Wang, MD, Yalan Wang, MD, Aichun Liu, MD, Jingwen Wang, MD, Yuankai Shi, MD, Ming Yuan, Xiaohui He, MD
Journal: Blood
Blood (2016) 128 (22): 4228.
https://doi.org/10.1182/blood.V128.22.4228.4228
Published: 2016
Journal Articles

The Identification of Novel Therapies for the Treatment of Follicular Dendritic Cell Sarcoma

Bo Wang, MD, Liang Zhang, MD PhD, Lan Pham, PhD, Wenjing Tao, PhD, Hui Zhang, Jingmeng Xie, Wendy Chen, Qingqing Cai, MD PhD, Dehui Zou, MD PhD, Donglu Zhao, MD, Xiuhua Sun, MDPhD, Rong Liang, MD PhD, Jack Wang, Krystle Nomie, PhD, Nathan Fowler, MD, Michael Wang, MD
Journal: Blood
Blood (2015) 126 (23): 5126.
https://doi.org/10.1182/blood.V126.23.5126.5126
Published: 2015
Journal Articles

A Phase II Study of MESA Chemotherapy for Newly Diagnosed, Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of Northern-West of China

Rong Liang, PhD MD, Gao Guangxun, PhD MD, Chen Jie Ping, PhD MD, Jishi Wang, Xiao min Wang, PhD MD, Yun Zeng, PhD MD, Xie qun Chen, PhD MD, Liang Zhang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3945.
https://doi.org/10.1182/blood.V126.23.3945.3945
Published: 2015
Journal Articles

Increased 14-3-3ζ Expression In The Multidrug-Resistant Leukemia Cell Line HL-60/Vcr As Compared To HL-60 Cell Line Mediates Cell Growth and Apoptosis

Rong Liang, PhD MD, Xiequn qun Chen, PhD MD, Qing xian Bai, PhD MD, Zhe Wang, PhD MD, Lan Yang, PhD MD, Tao Zhang, PhD MD, Bao xian Dong, PhD MD, Guang xun Gao, phD MD, Hong tao Gu, phD MD, Liang Zhang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5009.
https://doi.org/10.1182/blood.V122.21.5009.5009
Published: 2013
Journal Articles

Clinical Analysis Of 120 Cases Of Natural Killer/T Cell Lymphoma, Nasal Type By Single Hospital In The North-Western China

Rong Liang, PhD MD, Xie qun Chen, Sr, PhD MD, Zhe Wang, PhD MD, Bai qin Xian, PhD MD, qin-Guo guo Yan, PhD MD, Lan Yang, PhD MD, Lan Yang, PhD MD, Tao Zhang, PhD MD, Hong tao Gu, PhD MD, bao-Xia xia Dong, PhD MD, Guang xun Gao, PhD MD, Guang xun Gao, PhD MD, mi-Mi mi Shu, MD, Liang Zhang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5111.
https://doi.org/10.1182/blood.V122.21.5111.5111
Published: 2013
Journal Articles

Study On the Expression of 14-3-3ζ in Acute Myeloid Leukemic Cell Lines

Rong Liang, PhD MD, Hua Xiong, PhD MD, Zhe Wang, PhD MD, Qun xie Chen, PhD MD, Xun guang Gao, PhD MD, Xia bao Dong, PhD MD, Liang Zhang, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4820.
https://doi.org/10.1182/blood.V120.21.4820.4820
Published: 2012
Journal Articles

Analysis of Clinical and Pathological Features of 117 Chinese Cases of Natural Killer/T Cell Lymphoma

Rong Liang, PhD, MD, Zhe Wang, PhD, MD, Qun xie Chen, PhD, MD, Xian qing Bai, PhD, MD, Guo qing Yan, PhD, MD, Lan Yang, MD, Tao Zhang, PhD, MD, Ying Guo, PhD, MD, Luhua Wang, M.D.
Journal: Blood
Blood (2012) 120 (21): 5105.
https://doi.org/10.1182/blood.V120.21.5105.5105
Published: 2012